Daniel R. Passeri
2019 - Cue Biopharma
In 2019, Daniel R. Passeri earned a total compensation of $1.2M as Chief Executive Officer at Cue Biopharma, a 44% increase compared to previous year.
Compensation breakdown
| Bonus | $187,625 |
|---|---|
| Option Awards | $610,225 |
| Salary | $395,000 |
| Other | $5,764 |
| Total | $1,198,614 |
Passeri received $610.2K in option awards, accounting for 51% of the total pay in 2019.
Passeri also received $187.6K in bonus, $395K in salary and $5.8K in other compensation.
Rankings
In 2019, Daniel R. Passeri's compensation ranked 8,440th out of 13,971 executives tracked by ExecPay. In other words, Passeri earned more than 39.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,440 out of 13,971 | 40th |
Division Manufacturing | 3,343 out of 5,701 | 41st |
Major group Chemicals And Allied Products | 1,266 out of 2,200 | 43rd |
Industry group Drugs | 1,076 out of 1,886 | 43rd |
Industry Pharmaceutical Preparations | 799 out of 1,398 | 43rd |
Source: SEC filing on May 29, 2020.
Passeri's colleagues
We found three more compensation records of executives who worked with Daniel R. Passeri at Cue Biopharma in 2019.